These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 8698500)

  • 1. Natural immune response to the C-terminal 19-kilodalton domain of Plasmodium falciparum merozoite surface protein 1.
    Shi YP; Sayed U; Qari SH; Roberts JM; Udhayakumar V; Oloo AJ; Hawley WA; Kaslow DC; Nahlen BL; Lal AA
    Infect Immun; 1996 Jul; 64(7):2716-23. PubMed ID: 8698500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human IgG subclass antibodies to the 19 kilodalton carboxy terminal fragment of Plasmodium falciparum merozoite surface protein 1 (MSP1(19)) and predominance of the MAD20 allelic type of MSP1 in Uganda.
    Apio B; Nalunkuma A; Okello D; Riley E; Egwang TG
    East Afr Med J; 2000 Apr; 77(4):189-93. PubMed ID: 12858901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-variant specific antibody responses to the C-terminal region of merozoite surface protein-1 of Plasmodium falciparum (PfMSP-1(19)) in Iranians exposed to unstable malaria transmission.
    Zakeri S; Mehrizi AA; Zoghi S; Djadid ND
    Malar J; 2010 Sep; 9():257. PubMed ID: 20846388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgG subclass antibodies to three variants of Plasmodium falciparum merozoite surface protein-1 (PfMSP-1(19)) in an area with unstable malaria transmission in Iran.
    Mehrizi AA; Asgharpour S; Salmanian AH; Djadid ND; Zakeri S
    Acta Trop; 2011 Aug; 119(2-3):84-90. PubMed ID: 21609709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of antibodies to Plasmodium falciparum merozoite surface protein-4 with protection against clinical malaria.
    Perraut R; Varela ML; Joos C; Diouf B; Sokhna C; Mbengue B; Tall A; Loucoubar C; Touré A; Mercereau-Puijalon O
    Vaccine; 2017 Dec; 35(48 Pt B):6720-6726. PubMed ID: 29042203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular and humoral immune responses to well-defined blood stage antigens (major merozoite surface antigen) of Plasmodium falciparum in adults from an Indian zone where malaria is endemic.
    Kabilan L; Sharma VP; Kaur P; Ghosh SK; Yadav RS; Chauhan VS
    Infect Immun; 1994 Feb; 62(2):685-91. PubMed ID: 8300225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical immunity to Plasmodium falciparum malaria is associated with serum antibodies to the 19-kDa C-terminal fragment of the merozoite surface antigen, PfMSP-1.
    Egan AF; Morris J; Barnish G; Allen S; Greenwood BM; Kaslow DC; Holder AA; Riley EM
    J Infect Dis; 1996 Mar; 173(3):765-9. PubMed ID: 8627050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analysis of the profiles of IgG subclass-specific responses to Plasmodium falciparum apical membrane antigen-1 and merozoite surface protein-1 in naturally exposed individuals living in malaria hypoendemic settings, Iran.
    Rouhani M; Zakeri S; Mehrizi AA; Djadid ND
    Malar J; 2015 Feb; 14():58. PubMed ID: 25652589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential antibody recognition of four allelic variants of the merozoite surface protein-2 (MSP-2) of Plasmodium falciparum.
    Tonhosolo R; Wunderlich G; Ferreira MU
    J Eukaryot Microbiol; 2001; 48(5):556-64. PubMed ID: 11596920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum antibodies from malaria-exposed people recognize conserved epitopes formed by the two epidermal growth factor motifs of MSP1(19), the carboxy-terminal fragment of the major merozoite surface protein of Plasmodium falciparum.
    Egan AF; Chappel JA; Burghaus PA; Morris JS; McBride JS; Holder AA; Kaslow DC; Riley EM
    Infect Immun; 1995 Feb; 63(2):456-66. PubMed ID: 7822010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of T and B cell epitopes recognized by humans in the C-terminal 42-kDa domain of the Plasmodium falciparum merozoite surface protein (MSP)-1.
    Udhayakumar V; Anyona D; Kariuki S; Shi YP; Bloland PB; Branch OH; Weiss W; Nahlen BL; Kaslow DC; Lal AA
    J Immunol; 1995 Jun; 154(11):6022-30. PubMed ID: 7538540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Plasmodium falciparum merozoite surface protein-1 19 KD antibody response in the Peruvian Amazon predominantly targets the non-allele specific, shared sites of this antigen.
    Sutton PL; Clark EH; Silva C; Branch OH
    Malar J; 2010 Jan; 9():3. PubMed ID: 20047674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term clinical protection from falciparum malaria is strongly associated with IgG3 antibodies to merozoite surface protein 3.
    Roussilhon C; Oeuvray C; Müller-Graf C; Tall A; Rogier C; Trape JF; Theisen M; Balde A; Pérignon JL; Druilhe P
    PLoS Med; 2007 Nov; 4(11):e320. PubMed ID: 18001147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody responses and avidity of naturally acquired anti-Plasmodium vivax Duffy binding protein (PvDBP) antibodies in individuals from an area with unstable malaria transmission.
    Zakeri S; Babaeekhou L; Mehrizi AA; Abbasi M; Djadid ND
    Am J Trop Med Hyg; 2011 Jun; 84(6):944-50. PubMed ID: 21633032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicted and observed alleles of Plasmodium falciparum merozoite surface protein-1 (MSP-1), a potential malaria vaccine antigen.
    Qari SH; Shi YP; Goldman IF; Nahlen BL; Tibayrenc M; Lal AA
    Mol Biochem Parasitol; 1998 May; 92(2):241-52. PubMed ID: 9657329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human immune response in Plasmodium falciparum malaria. Synthetic peptides corresponding to known epitopes of the Pf155/RESA antigen induce production of parasite-specific antibodies in vitro.
    Chougnet C; Troye-Blomberg M; Deloron P; Kabilan L; Lepers JP; Savel J; Perlmann P
    J Immunol; 1991 Oct; 147(7):2295-301. PubMed ID: 1717554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epitope analysis of human T-cell response to MSP-1 of Plasmodium falciparum in malaria-nonexposed individuals.
    Ohta N; Iwaki K; Itoh M; Fu J; Nakashima S; Hato M; Tolle R; Bujard H; Saitoh A; Tanabe K
    Int Arch Allergy Immunol; 1997 Sep; 114(1):15-22. PubMed ID: 9303326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological cross-reactivity of the C-terminal 42-kilodalton fragment of Plasmodium falciparum merozoite surface protein 1 expressed in baculovirus.
    Hui GS; Hashiro C; Nikaido C; Case SE; Hashimoto A; Gibson H; Barr PJ; Chang SP
    Infect Immun; 1993 Aug; 61(8):3403-11. PubMed ID: 7687586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between protection against clinical malaria and antibodies to merozoite surface antigens in an area of hyperendemicity in Myanmar: complementarity between responses to merozoite surface protein 3 and the 220-kilodalton glutamate-rich protein.
    Soe S; Theisen M; Roussilhon C; Aye KS; Druilhe P
    Infect Immun; 2004 Jan; 72(1):247-52. PubMed ID: 14688102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgG3 antibodies to Plasmodium falciparum merozoite surface protein 2 (MSP2): increasing prevalence with age and association with clinical immunity to malaria.
    Taylor RR; Allen SJ; Greenwood BM; Riley EM
    Am J Trop Med Hyg; 1998 Apr; 58(4):406-13. PubMed ID: 9574783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.